Breaking News
April 18, 2019 - Diabetic drug shows potential to be repurposed as heart disease treatment for non-diabetic patients
April 18, 2019 - New estimation method assesses natural variations in sex ratio at birth
April 18, 2019 - UTA scientist receives $1.17 million grant for cancer research
April 18, 2019 - Coagulation factor VIIa prevents bleeds in hemophilia animal models
April 18, 2019 - Researchers identify risk factors for severe infection after knee replacement
April 18, 2019 - Mass drug administration can offer community-level protection against malaria
April 18, 2019 - FDA’s added sugar label could have substantial health and cost-saving benefits
April 18, 2019 - Researchers identify cause of inherited metabolic disorder
April 18, 2019 - Single strip of white paint not sufficient to protect people who ride bikes
April 18, 2019 - Partner status influences link between sexual problems and self-efficacy in breast cancer survivors
April 18, 2019 - Colorectal Neoplasia Risk Up for Hodgkin Lymphoma Survivors
April 18, 2019 - Rigid spine muscular dystrophy – Genetics Home Reference
April 18, 2019 - Simple bile acid blood test could tell risk of stillbirth
April 18, 2019 - Center for Experimental Therapeutics aims to enable all steps of drug development | News Center
April 18, 2019 - Falling for telephone scams could be an early sign of dementia
April 18, 2019 - Researchers annotate key neuronal proteins in lamprey genome
April 18, 2019 - Study uncovers new biomarker for personalized cancer treatments
April 18, 2019 - Scientists enter research collaboration to find a cure for cancer
April 18, 2019 - Study to compare benefits of tai chi and mindfulness meditation on MS symptoms
April 18, 2019 - Gestational diabetes during pregnancy may increase risk of type 1 diabetes in children
April 18, 2019 - Is a New Remedy for Body Odor on the Horizon?
April 18, 2019 - Orthostatic hypotension – Genetics Home Reference
April 18, 2019 - Healing the heartbreak of stillbirth and newborn death
April 18, 2019 - Conference to highlight advances in human immune monitoring, bioinformatics | News Center
April 18, 2019 - Bacteria use viruses for self-recognition, study reveals
April 18, 2019 - New adhesive patch could help reduce post-heart attack muscle damage
April 18, 2019 - Researchers analyze the effects of dark play in a serious video game
April 18, 2019 - Filial cannibalism and offspring abandonment may be forms of parental care
April 18, 2019 - Two proteins act in concert to maintain a healthy heart in mice, shows study
April 18, 2019 - Scientists create a functioning 3D printed heart
April 18, 2019 - Non-invasive vagus nerve stimulation improves disease symptoms in patients with rheumatoid arthritis
April 18, 2019 - Majority of men struggle to understand diagnosis and treatment of prostate cancer
April 18, 2019 - Researchers create new small molecules that may combat equine encephalitis viruses
April 18, 2019 - Animal-assisted therapy improves social behavior in patients with brain injuries
April 18, 2019 - Some viruses help protect harmful bacteria in CF patients | News Center
April 18, 2019 - Outpatient healthcare providers inappropriately prescribe antibiotics to 40% of patients
April 18, 2019 - Men who have a resting heart rate of 75 bpm are twice as likely to die early
April 18, 2019 - Novel serum biomarkers to detect NAFLD-related fibrosis
April 18, 2019 - New study delves deeper into individual genomic differences than ever before
April 18, 2019 - Gilead and Galapagos Announce Filgotinib Meets Primary Endpoint in the Phase 3 FINCH 3 Study in Methotrexate-Naïve Rheumatoid Arthritis Patients
April 18, 2019 - Emotional mirror neurons found in rats
April 18, 2019 - Sylvia Plevritis appointed chair of biomedical data science | News Center
April 18, 2019 - Yeast strain provides manufacturing boost to low-calorie sweetener derived from lactose
April 18, 2019 - One in five children and youth suffer from a mental disorder
April 18, 2019 - Improper inhaler use common in children with asthma
April 18, 2019 - C-Path and CDISC release global Therapeutic Area Standard for HIV research
April 18, 2019 - Integrating AI to analyze imaging data allows early recognition of heart disease
April 18, 2019 - Low-cost, high-speed algorithm may allow animal-free chemical toxicity testing
April 18, 2019 - HPV-negative cervical cancers are more aggressive with worse prognosis
April 18, 2019 - AI detects prostate cancer with same level of accuracy as experienced radiologists
April 18, 2019 - Study resolves sex differences in psychiatric illness risk
April 18, 2019 - Novartis Announces FDA Filing Acceptance and Priority Review of Brolucizumab (RTH258) for Patients with Wet AMD
April 18, 2019 - Cocktail of common antibiotics can fight resistant E. coli
April 18, 2019 - Persis Drell to give keynote address at medical school diploma ceremony | News Center
April 18, 2019 - EpicTogether: Remembering Our Why
April 18, 2019 - Study identifies novel loci contributing to asthma susceptibility in adults
April 18, 2019 - Gut bacteria and pregnancy
April 18, 2019 - New study finds that screening could help prevent rare types of cervical cancer
April 17, 2019 - Spatial orgnization of the genome can be altered using small molecules
April 17, 2019 - AEDs Tied to Higher Pneumonia Risk in Alzheimer Patients
April 17, 2019 - Telemedicine tied to more antibiotics for kids, study finds
April 17, 2019 - Two medical students awarded 2019 Soros Fellowships for New Americans | News Center
April 17, 2019 - Sociologist Constance A. Nathanson Awarded Guggenheim Fellowship
April 17, 2019 - Empathy and hormones could account for aggressive behavior in children, shows study
April 17, 2019 - Researchers develop oral appliance to help sufferers of sleep apnea
April 17, 2019 - Neuronal transport factor detects its target transcripts in more complex manner than previously thought
April 17, 2019 - New drug-delivery system senses high oxidant levels, responds to body chemistry and environment
April 17, 2019 - Health Tip: Horseback Trail Riding Safety
April 17, 2019 - Scientists outline the promises and pitfalls of machine learning in medicine
April 17, 2019 - $12 million grant renewal for flu vaccine research | News Center
April 17, 2019 - Lisa Kachnic, MD, Joins Columbia University as Chair of Radiation Oncology
April 17, 2019 - New study sheds light on how extreme temperature hampers spermatogenesis in insects
April 17, 2019 - Study tests high-tech, non-pharmaceutical way to address ADHD and distractibility
April 17, 2019 - New EZ-2 evaporator for clinical biochemistry sample preparation
April 17, 2019 - Fat shaming celebrities may make women more judgemental about being overweight
April 17, 2019 - Magic mouthwash effectively reduces mouth sore pain caused by radiation therapy
April 17, 2019 - CBD could help slip medications into the brain
April 17, 2019 - Scientists characterize 2017 pneumonic plague outbreak in Madagascar
April 17, 2019 - Human iPSC-derived MSCs from aged individuals acquire a rejuvenation signature
April 17, 2019 - Gun Research Is Suddenly Hot
CEA Test: MedlinePlus Lab Test Information

CEA Test: MedlinePlus Lab Test Information

image_pdfDownload PDFimage_print

What is a CEA test?

CEA stands for carcinoembryonic antigen. It is a protein found in the tissues of a developing baby. CEA levels normally become very low or disappear after birth. Healthy adults should have very little or no CEA in their body.

This test measures the amount of CEA in the blood, and sometimes in other body fluids. CEA is a type of tumor marker. Tumor markers are substances made by cancer cells or by normal cells in response to cancer in the body.

A high level of CEA can be a sign of certain types of cancers. These include cancers of the colon and rectum, prostate, ovary, lung, thyroid, or liver. High CEA levels may also be a sign of some noncancerous conditions, such as cirrhosis, noncancerous breast disease, and emphysema.

A CEA test can’t tell you what kind of cancer you have, or even whether you have cancer. So the test is not used for cancer screening or diagnosis. But if you’ve already been diagnosed with cancer, a CEA test can help monitor the effectiveness of your treatment and/or help find out if the disease has spread to other parts of your body.

Other names: CEA assay, CEA blood test, carcinoembryonic antigen test

What is it used for?

A CEA test may be used to:

  • Monitor treatment of people with certain types of cancers. These include colon cancer and cancers of the rectum, prostate, ovary, lung, thyroid, and liver.
  • Figure out the stage of your cancer. This means checking the size of the tumor and how far the cancer has spread.
  • See if cancer has returned after treatment.

Why do I need a CEA test?

You may need this test if you’ve been diagnosed with cancer. Your health care provider may test you before you start treatment, and then regularly throughout the course of your therapy. This can help your provider see how well your treatment is working. You may also get a CEA test after you’ve completed treatment. The test can help show whether the cancer has come back.

What happens during a CEA test?

CEA is usually measured in the blood. During a CEA blood test, a health care professional will take a blood sample from a vein in your arm, using a small needle. After the needle is inserted, a small amount of blood will be collected into a test tube or vial. You may feel a little sting when the needle goes in or out. This usually takes less than five minutes.

Sometimes, CEA is tested in the spinal fluid or from fluid in the abdominal wall. For these tests, your provider will remove a small sample of fluid using a thin needle and/or syringe. The following fluids may be tested:

  • Cerebrospinal fluid (CSF), a clear, colorless liquid found in the spinal cord
  • Peritoneal fluid, a fluid that lines your abdominal wall
  • Pleural fluid, a liquid inside your chest cavity that covers the outside of each lung

Will I need to do anything to prepare for the test?

You don’t need any special preparations for a CEA blood test or a pleural fluid test.

You may be asked to empty your bladder and bowels before a CSF or peritoneal fluid test.

Are there any risks to the test?

There is very little risk to having a CEA blood test. You may have slight pain or bruising at the spot where the needle was put in, but most symptoms go away quickly.

CEA tests of body fluids are usually very safe. Serious problems are rare. But you may experience one or more of the following side effects:

  • If you had a CSF test, you may feel some pain or tenderness in your back at the site where the needle was inserted. Some people get a headache after the test. This is called a post-lumbar headache.
  • If you had a peritoneal fluid test, you may feel a little dizzy or lightheaded after the procedure. There is a small risk of damage to the bowel or bladder, which may cause an infection.
  • If you had a pleural fluid test, there is a small risk of lung damage, infection, or blood loss.

What do the results mean?

If you were tested before you started treatment for cancer, your results may show:

  • A low level of CEA. This may mean your tumor is small and the cancer has not spread to other parts of your body.
  • A high level of CEA. This may mean you have a larger tumor and/or your cancer may have spread.

If you are being treated for cancer, you may be tested several times throughout treatment. These results may show:

  • Your levels of CEA started high and remained high. This may mean your cancer is not responding to treatment.
  • Your levels of CEA started high but then decreased. This may mean your treatment is working.
  • Your CEA levels decreased, but then later increased. This may mean your cancer has come back after you’ve been treated.

If you had a test on a body fluid (CSF, peritoneal, or pleural), a high level of CEA may mean the cancer has spread to that area.

If you have questions about your results, talk to your health care provider.

Is there anything else I need to know about a CEA test?

Many cancers don’t produce CEA. If your CEA results were normal, you may still have cancer. Also, high levels of CEA can be sign of a noncancerous health condition. In addition, people who smoke cigarettes often have higher than normal CEA levels.

Tagged with:

About author

Related Articles